StockData
SSIINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

SS Innovations International, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$2.45−0.08 (-3.16%)

Close on Oct 19, 2026

Market cap
$513.09M
P/E (TTM)
–
Dividend yield
–

About SS Innovations International

Surgical & Medical Instruments & Apparatus, SIC 3841

SS Innovations International designs, manufactures, and markets robotic surgical systems, instruments, and digital platforms. Its core offering is the SSi Mantra robotic system, which supports procedures across specialties including general surgery, urology, gynecology, colorectal, thoracic, and cardiac surgery. The company also provides the SSi Mudra line of reusable surgical instruments, accessories, telesurgery systems, and maintenance services. Its primary customers are hospitals, surgical centers, and healthcare providers.

The company's installed base comprises 168 robotic systems deployed across 153 hospitals in 10 countries, including 154 units in India and 14 in overseas locations. Surgeons have utilized these systems to perform more than 7,800 operations, including over 120 telesurgeries. In addition to India, the company maintains regulatory approvals in countries such as Colombia, Ecuador, Guatemala, Indonesia, Kenya, Oman, the Philippines, Sri Lanka, Ukraine, and the United Arab Emirates. Its principal executive offices are located in Gurugram, India.

Summary of the business section of SS Innovations International's latest annual report, written by StockData.

Company profile

Company

Legal name
SS Innovations International, Inc.
Founded
2015
Headquarters
Gurugram, India
Address
405, 3rd Floor, Ilabs Info Tech Centre, Udyog Vihar, Phase Iii 122016
Phone
(954) 478-1410
Employees
81, Dec 31, 2025
Industry
Surgical & Medical Instruments & Apparatus
Incorporated in
Florida
Fiscal year ends
December 31
Auditor
BDO India Services Private Limited, Gurugram, India

Stock & identifiers

Ticker
SSII
Exchange
Nasdaq
IPO date
Aug 7, 2024
Shares outstanding
200M, Aug 12, 2026
Public float
$270.11M, Jun 30, 2025
Filer category
Non-accelerated filer<br>Smaller reporting company
Stock splits
13-for-4, Nov 14, 2024
SEC CIK
1676163
CUSIP
05453U203
ISIN
US05453U2033
LEI
549300R1NOCJPRJEMP71
EIN
47-3478854

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Srivastava SudhirChairman and CEO, Director108,520,928
Pascual Srivastava VishwajyotiCEO - Asia Pacific, Director3,000,000
Barry F. CohenCOO - Americas, Director7,755,088
Sarah RomanoCFO–
Milan RaoGlobal COO and CFO120,000
Naveen Kumar AmarCFO0
Arvind Palaniappan PalaniappanInterim CFO0
Kumar Sethi AnupCFO885,592
Timothy P. AdamsDirector5,331,902
Frederic H. MollDirector20,836,298
Sampige Prasannakumar SomashekarDirector291,165

Employees

Headcount reported in annual reports

“staff and currently have a research and development team of 81 employees to focus on delivering future innovations and sustaining improvements”

Corporate history

Events identified from SEC filings

DateEventDetails
Apr 24, 2025ListingRegistration of securities on an exchange (Form 8-A)
Mar 31, 2025Late filingNotification of late filing
May 31, 2024Auditor changeChange in certifying accountant (8-K Item 4.01)
May 13, 2024Auditor changeChange in certifying accountant (8-K Item 4.01)
Jun 26, 2023Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Apr 19, 2023Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Apr 14, 2023Name changeName changed from AVRA Medical Robotics, Inc. to SS Innovations International, Inc.
Sep 14, 2021Auditor changeChange in certifying accountant (8-K Item 4.01)
Jan 29, 2021Auditor changeChange in certifying accountant (8-K Item 4.01)
May 15, 2020Late filingNotification of late filing
Mar 29, 2019Late filingNotification of late filing
May 15, 2018Late filingNotification of late filing